Growth Company Investor - Stock market recommendations on AIM and small cap companies

30 November 2015

Popular Topics within deals & contracts

US ally for Avia 

Avia Health Informatics has appointed telemedicine and tele-health specialist Lifebot as first US re-seller of its clinical decision software.  

Tags: AIM, Deals & contracts, Fundraisings, PLUS Markets

Infrastrata pares first-half loss

Gas storage play Infrastrata has cut interim losses 17.5 per cent to £636,552 as it prepares to farm out its key project.

Tags: AIM, Deals & contracts, Fundraisings

Oracle in funding talks

Pakistan brown coal play Oracle Coalfields is talking to local banks about backing its £129 million Thar project in Sindh Province. 

Tags: Deals & contracts, Fundraisings, PLUS Markets

Intelligent Environments' profits slip

Online financial software specialist Intelligent Environments' pre-tax profits have fallen 37 per cent to £862,451 after £1.15 million of project cancellations.

Tags: AIM, Deals & contracts, Mergers & acquisitions, Speculative punts

Profits growth at Rotala

Midlands bus operator Rotala sounds bullish after driving annual profits 25 per cent ahead to £1.5 million pre-tax.

Tags: AIM, Deals & contracts, Growth Stocks

First Property weathers the storm

Poland-focused First Property Group says it has come through a testing year profitable and 'in very good' shape.

Tags: AIM, Deals & contracts, Fundraisings

Aurelian prepares major drilling

Eastern Europe-focused Aurelian Oil & Gas has slashed annual losses and plans a crucial drilling programme in Poland.

Tags: AIM, Deals & contracts, Growth Stocks

Asterand into the red

Human tissue and related research services provider Asterand turned a £4 million profit into a £1.3 million loss last year.

Tags: Cash, Deals & contracts, Full list

Japanese buy into Kalahari

ITOCHU Corporation, a major Japanese trading house, has bought 15 per cent of uranium play Kalahari Minerals.

Tags: AIM, Boardroom moves, Deals & contracts

Adventis profits slip

Pre-tax profits at marketing services, media buying and advertising group Adventis fell 28 per cent last year to £1.3 million.

Tags: AIM, Deals & contracts, Fundraisings, Restructuring

Trial data cheers GW Pharma

GW Pharmaceuticals says Phase IIb preliminary results for its Sativex cancer pain treatment support moving to the next US trial phase.

Tags: AIM, Deals & contracts

New orders for SRT

Secure communication specialist Software Radio Technology (SRT) has won $1.46 million (£976,000) of orders for its new AIS Class A transceiver.

Tags: AIM, Deals & contracts, Turnaround

Cash Shells 2015

Published in September 2015 this annual research report provides a comprehensive overview of cash shells on the Main Market, AIM and PLUS landscape. Order your copy today


Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

FREE Step-by-Step Guide to Investment Analysis

Read Phil Oakley’s easy-to-read guide to analysing shares. Learn how to become a confident & successful stock-picker. A must-read for novice and experienced investors alike. Click here to read.

What moves small-cap share prices?

A research report into the top-performing 100 companies below the FTSE 350 and on AIM. Click here to download.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info


Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

What Investment magazine: save 45% on the shop price

Be the first to receive our independent analysis and research, designed to help you generate more wealth for you and your family over the long term. Subscribe and save.

Popular Topics